The Strategy for Enhancing Temozolomide Against Malignant Glioma

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2012.00098
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Bevacizumab Monotherapy for Temozolomide-Refractory Malignant Glioma

Japanese Journal of Neurosurgery
SurgeryNeurology
2010English

Impact of Temozolomide on Immune Response During Malignant Glioma Chemotherapy

Clinical and Developmental Immunology
2012English

Virotherapy Against Malignant Glioma Stem Cells

Cancer Letters
Cancer ResearchOncology
2010English

Benefits Afforded by Combined Temozolomide, Radiation and Stem Cell Strategy for Glioma Therapy

Tropical Journal of Pharmaceutical Research
PharmacologyPharmaceutical Science
2017English

Inhibition of Elongation Factor-2 Kinase Augments the Antitumor Activity of Temozolomide Against Glioma

PLoS ONE
Multidisciplinary
2013English

MicroRNA-93 Promotes the Malignant Phenotypes of Human Glioma Cells and Induces Their Chemoresistance to Temozolomide

Biology Open
BiochemistryAgriculturalGeneticsMolecular BiologyBiological Sciences
2016English

Gene Therapy for Malignant Glioma

Molecular and Cellular Therapies
2014English

Gene Therapy for Malignant Glioma

Japanese Journal of Neurosurgery
SurgeryNeurology
2003English

Polifeprosan 20, 3.85% Carmustine Slow-Release Wafer in Malignant Glioma: Evidence for Role in Era of Standard Adjuvant Temozolomide

Core Evidence
MedicineReviewsReferencesPharmacology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy